Inflammatory bowel disease as a risk factor for premature coronary artery disease

scientific article

Inflammatory bowel disease as a risk factor for premature coronary artery disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.14740/JOCMR2102W
P932PMC publication ID4330019
P698PubMed publication ID25699123
P5875ResearchGate publication ID272370225

P2093author name stringAmgad N Makaryus
Michael Ruisi
John N Makaryus
Phillip Ruisi
P2860cites workIncreasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewQ22250934
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influencesQ29617565
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusQ34098573
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritisQ34182804
Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.Q34542615
Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort studyQ34607215
Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studiesQ35030705
Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysisQ36677630
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of GastroenterologyQ40390478
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort studyQ44355973
Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.Q45002674
Is inflammatory bowel disease a risk factor for early atherosclerosis?Q46034527
Increased carotid intima-media thickness in patients with inflammatory bowel diseaseQ46753185
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.Q50553326
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.Q55033683
Arterial stiffness is increased in patients with inflammatory bowel diseaseQ57662373
Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosusQ60692382
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsQ77406810
Inflammatory bowel disease is not associated with increased intimal media thickeningQ79806148
Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseasesQ87296439
P433issue4
P921main subjectrisk factorQ1475848
coronary artery diseaseQ844935
inflammatory bowel diseasesQ917447
P304page(s)257-261
P577publication date2015-02-09
P1433published inJournal of Clinical Medicine ResearchQ26842453
P1476titleInflammatory bowel disease as a risk factor for premature coronary artery disease
P478volume7

Reverse relations

cites work (P2860)
Q54446718Atherosclerosis in Inflammatory Bowel Disease.
Q37540172Care of inflammatory bowel disease patients in remission
Q26774558Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications
Q28551995Generating Gene Ontology-Disease Inferences to Explore Mechanisms of Human Disease at the Comparative Toxicogenomics Database
Q92219050PPAR γ/Nnat/NF-κB Axis Involved in Promoting Effects of Adiponectin on Preadipocyte Differentiation
Q28078112Preventive health measures in inflammatory bowel disease
Q52859380Psoriasis and inflammatory bowel disease: links and risks.
Q55026430Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets.